Merz Aesthetics introduces new brand to China

Back in 2022, Merz Aesthetics introduced the premium hyaluronic acid dermal filler brand BELOTERO and its first product BELOTERO BALANCE LIDOCAINE on the Chinese mainland for the management of moderate nasolabial folds. And this year, BELOTERO VOLUME LIDOCAINE just obtained registration approval from the National Medical Products Administration.

The BELOTERO series of products are manufactured using the innovative Dynamic Cross-Linking Technology ("DCLT") giving rise to a Cohesive Polydensified Matrix ("CPM"), designed for optimal tissue integration. They can be used individually or in combination, depending on the skin's structural and functional needs.

Merz Aesthetics' Chief Scientific Officer Samantha Kerr shared the unique features of CPM technology at the event: "CPM technology refers to a patented technology that creates multiple areas of differing densities within a hyaluronic acid gel. This technology allows the gel to have both high-density areas and low-density areas, resulting in enhanced tissue integration and cohesivity. The BELOTERO range offers products with customized rheological properties that are suited to based on different anatomical layers and the structural and functional needs of the skin, enabling healthcare professionals to provide personalized aesthetic solutions."

Experts at the conference discussed and explored Merz Aesthetics' innovative and cutting-edge hyaluronic acid technology. They explained the CPM patented cross-linking technology from various professional perspectives on how technology can shape personalized and authentic beauty. They also highlighted the unique characteristics of BELOTERO VOLUME, helping Chinese medical aesthetics professionals achieve more.

The climax of the event was the launch of BELOTERO VOLUME, when the Asia-Pacific management team of Merz Aesthetics and top experts from China and abroad took to the stage together to witness the official entry of BELOTERO VOLUME into the Chinese mainland market.